Pneumoconiosis
Showing 1 - 25 of 47
Pneumoconiosis Trial (Pirfenidone Capsules, capsules)
Not yet recruiting
- Pneumoconiosis
- Pirfenidone Capsules
- placebo capsules
- (no location specified)
Mar 16, 2022
Potential of Deep Learning in Assessing Pneumoconiosis Depicted
Completed
- Pneumoconiosis
- convolutional neural networks (CNNs)
- (no location specified)
Jul 8, 2021
Evaluation of Pneumoconiosis High Risk Early Warning Models
Recruiting
- Pneumoconiosis
-
Beijing, Beijing, ChinaPeking University Third Hospital
Jul 2, 2021
Interstitial Lung Disease, Idiopathic Interstitial Pneumonias, Drug-Induced Pneumonitis Trial in Los Angeles (68Ga-FAPi-46,
Recruiting
- Interstitial Lung Disease
- +6 more
- 68Ga-FAPi-46
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
May 6, 2022
Coal Worker's Pneumoconiosis Trial in Zhengzhou (Chinese medicine compound combined with symptomatic treatments, Chinese
Recruiting
- Coal Worker's Pneumoconiosis
- Chinese medicine compound combined with symptomatic treatments
- Chinese medicine compound placebo combined with symptomatic treatments
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Henan University of Traditional
Apr 8, 2021
Patients and Family Caregivers in Managing Pneumoconiosis in
Completed
- Pneumoconiosis
- No intervention
-
Hong Kong, Hong KongPneumoconiosis Compensation Fund Board
Jan 27, 2021
Pneumoconiosis Coal, Asbestosis, Silicosis Trial in Sydney (Nintedanib 150 MG [Ofev])
Recruiting
- Pneumoconiosis Coal
- +2 more
- Nintedanib 150 MG [Ofev]
-
Sydney, New South Wales, AustraliaHoldsworth House Medical Practice
Feb 8, 2021
Pneumoconiosis Trial in Chongqing, Nanjing (large volume whole-lung lavage (WLL), clinical grade umbilical cord mesenchymal stem
Completed
- Pneumoconiosis
- large volume whole-lung lavage (WLL)
- clinical grade umbilical cord mesenchymal stem cells
-
Chongqing, Chongqing, China
- +1 more
Jul 23, 2019
Mechanical Ventilation, General Anesthesia, Urological Surgery Trial in Guangzhou (record Hemodynamic variables, respiratory
Completed
- Mechanical Ventilation
- +3 more
- record Hemodynamic variables, respiratory variables and arterial blood gas at specific times
-
Guangzhou, Guangdong, ChinaCai Xinyuan
Sep 20, 2023
Silicosis Trial in Brisbane
Recruiting
- Silicosis
-
Brisbane, Queensland, AustraliaThe Prince Charles Hospital
Sep 15, 2022
Effect of Phosphate Exposure on Workers Health
Not yet recruiting
- Work-related Illness
- chest x ray
- (no location specified)
Oct 23, 2021
Silicosis, Silicotic Fibrosis (Massive) of Lung Trial in Rwinkwavu (questionnaire, KAP)
Recruiting
- Silicosis
- Silicotic Fibrosis (Massive) of Lung
- questionnaire, KAP
-
Rwinkwavu, Kayonza, RwandaRwinkwavu District Hospital
Sep 8, 2022
COPD, Asthma, Lung Cancer Trial in Birmingham (N-Tidal C handset)
Completed
- COPD
- +9 more
- N-Tidal C handset
-
Birmingham, West Midlands, United KingdomModality Partnership
Dec 7, 2022
Identification Of Occupational Exposures In Patients With ILD
Completed
- Occupational Exposure
- Interstitial Lung Disease
- Professional course, occupational exposures
-
Pierre-Bénite, FranceCentre de consultation de pathologie professionnelle, Centre Hos
May 4, 2021
Idiopathic Pulmonary Fibrosis Trial in Paris (TLC1_TM6, TM6_TLC1)
Recruiting
- Idiopathic Pulmonary Fibrosis
- TLC1_TM6
- TM6_TLC1
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Sep 30, 2022
Lung Diseases, Rare Non-Neoplastic Disorder Trial in Morgantown (Intervention FamPALcare)
Completed
- Lung Diseases
- Rare Non-Neoplastic Disorder
- Intervention FamPALcare
-
Morgantown, West VirginiaWest Virginia University Hospital
Oct 18, 2019
Type 2 Diabetes Trial in Worldwide (efpeglenatide (SAR439977), )
Completed
- Type 2 Diabetes Mellitus
- efpeglenatide (SAR439977)
- placebo
-
Birmingham, Alabama
- +53 more
Jan 11, 2022
Rheumatoid Arthritis Trial in Worldwide (Abatacept, Methotrexate, Abatacept Placebo)
Type 2 Diabetes Trial in Worldwide (Bexagliflozin, Placebo)
Trajenta in Korean Type 2 Diabetes Mellitus
Completed
- Diabetes Mellitus, Type 2
- Trajenta tablet
-
Multiple Locations, Korea, Republic of(unnamed)
Jul 6, 2018
Pletaal SR Post Marketing Observational Study
Completed
- Ischemic Symptoms
- Cerebral Infarction
- This is Non-interventional study
-
Daegu, Korea, Republic of
- +3 more
Feb 12, 2019
Pneumoconiosis Trial in Hengyang (Human umbilical cord mesenchymal stem cells)
Unknown status
- Pneumoconiosis
- Human umbilical cord mesenchymal stem cells
-
Hengyang, Hunan, ChinaThe second Affiliated Hospital of University of Soth China
May 31, 2016